Skip to main content
Top
Published in:

Open Access 09-05-2024 | Chronic Kidney Disease | Original Research

Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study

Authors: Ewelina Palmer, Ichha Johar, Dustin J. Little, Niklas Karlsson

Published in: Advances in Therapy | Issue 7/2024

Login to get access

Abstract

Introduction

Limitations in physical functioning are common in patients with late-stage chronic kidney disease (CKD) and can greatly affect their lives. Using patient interviews, this study reports experiences associated with physical functioning limitations for patients with late-stage CKD.

Methods

A preliminary conceptual model on concepts relevant to physical functioning limitations in patients with CKD was developed using data from a targeted literature review (patients with CKD stages IV–V) and previous interviews (patients with CKD stages IIIa–IIIb). The preliminary conceptual model informed a semi-structured interview guide designed to capture experiences of physical functioning limitations in patients with CKD. Patients with CKD stages IV–V who were not receiving dialysis were interviewed; their responses were used to develop a comprehensive conceptual model summarizing their experiences associated with physical functioning limitations.

Results

A total of 25 patients with CKD stage IV (n = 19) or V (n = 6) were interviewed. Based on patient responses, the reported concepts were grouped into one of six categories: physical functioning limitations/difficulties, behavioural impacts, activity participation restrictions, symptoms attributed to physical functioning limitations, impacts on sleep and emotional functioning impacts related to physical functioning limitations. Twenty-three patients reported concepts associated with physical functioning limitations, most frequently ‘walking up and down stairs’ (83%) and ‘walking distances’ (74%). All 23 patients also reported behavioural impacts, including ‘need to rest/subsequent periods of rest’ (100%) and ‘participation in fewer activities’ (91%). As well as summarizing the reported concepts, the comprehensive conceptual model shows how concepts may relate to one another; for example, challenging symptoms or difficulty completing tasks can lead to changes in patient behaviour such as purposely reducing or avoiding activities.

Conclusions

This study found that patients with late-stage CKD not receiving dialysis who experience physical functioning limitations report a range of impacts on their daily lives. The comprehensive conceptual model summarizes the concepts reported and the relationships between them, providing a holistic understanding of how patients with late-stage CKD are affected by physical functioning limitations.
Infographic available for this article.

Infographic

Appendix
Available only for authorised users
Literature
2.
go back to reference Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRefPubMed Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.CrossRefPubMed
3.
go back to reference GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef
4.
go back to reference Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90.CrossRefPubMedPubMedCentral Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90.CrossRefPubMedPubMedCentral
6.
go back to reference Flythe JE, Karlsson N, Sundgren A, et al. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrol. 2021;22(1):233.CrossRefPubMedPubMedCentral Flythe JE, Karlsson N, Sundgren A, et al. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrol. 2021;22(1):233.CrossRefPubMedPubMedCentral
7.
go back to reference MacKinnon HJ, Wilkinson TJ, Clarke AL, et al. The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review. Ther Adv Chronic Dis. 2018;9(11):209–26.CrossRefPubMedPubMedCentral MacKinnon HJ, Wilkinson TJ, Clarke AL, et al. The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review. Ther Adv Chronic Dis. 2018;9(11):209–26.CrossRefPubMedPubMedCentral
8.
go back to reference Painter P, Stewart AL, Carey S. Physical functioning: definitions, measurement, and expectations. Adv Ren Replace Ther. 1999;6(2):110–23.CrossRefPubMed Painter P, Stewart AL, Carey S. Physical functioning: definitions, measurement, and expectations. Adv Ren Replace Ther. 1999;6(2):110–23.CrossRefPubMed
9.
go back to reference Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4(12):1901–6.CrossRefPubMedPubMedCentral Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009;4(12):1901–6.CrossRefPubMedPubMedCentral
10.
go back to reference Tsai Y, Chen H, Hsiao S, et al. Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease. PLoS ONE. 2017;12(8):e0183642.CrossRefPubMedPubMedCentral Tsai Y, Chen H, Hsiao S, et al. Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease. PLoS ONE. 2017;12(8):e0183642.CrossRefPubMedPubMedCentral
17.
go back to reference Walton MK, Powers JH 3rd, Hobart J, et al. Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment—emerging good practices for outcomes research task force. Value Health. 2015;18(6):741–52.CrossRefPubMedPubMedCentral Walton MK, Powers JH 3rd, Hobart J, et al. Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment—emerging good practices for outcomes research task force. Value Health. 2015;18(6):741–52.CrossRefPubMedPubMedCentral
18.
19.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2-assessing respondent understanding. Value Health. 2011;14(8):978–88.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2-assessing respondent understanding. Value Health. 2011;14(8):978–88.CrossRefPubMed
20.
go back to reference Reese PP, Cappola AR, Shults J, et al. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013;38(4):307–15.CrossRefPubMed Reese PP, Cappola AR, Shults J, et al. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013;38(4):307–15.CrossRefPubMed
21.
go back to reference Hiraki K, Yasuda T, Hotta C, et al. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(2):225–31.CrossRefPubMed Hiraki K, Yasuda T, Hotta C, et al. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(2):225–31.CrossRefPubMed
22.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–77.CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967–77.CrossRefPubMed
23.
go back to reference Rydén A, Nolan S, Maher J, Meyers O, Kündig A, Bjursell M. Understanding the patient experience of chronic kidney disease stages 2–3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief. BMC Nephrol. 2022;23(1):201.CrossRefPubMedPubMedCentral Rydén A, Nolan S, Maher J, Meyers O, Kündig A, Bjursell M. Understanding the patient experience of chronic kidney disease stages 2–3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief. BMC Nephrol. 2022;23(1):201.CrossRefPubMedPubMedCentral
24.
go back to reference Broers NJH, Martens RJH, Cornelis T, et al. Physical activity in end-stage renal disease patients: the effects of starting dialysis in the first 6 months after the transition period. Nephron. 2017;137(1):47–56.CrossRefPubMed Broers NJH, Martens RJH, Cornelis T, et al. Physical activity in end-stage renal disease patients: the effects of starting dialysis in the first 6 months after the transition period. Nephron. 2017;137(1):47–56.CrossRefPubMed
26.
go back to reference Krippendorf K. Reliability in content analysis: some common misconceptions and recommendations. Hum Commun Res. 2004;30(3):411–33. Krippendorf K. Reliability in content analysis: some common misconceptions and recommendations. Hum Commun Res. 2004;30(3):411–33.
28.
go back to reference Chen IR, Wang SM, Liang CC, et al. Association of walking with survival and RRT among patients with CKD stages 3–5. Clin J Am Soc Nephrol. 2014;9(7):1183–9.CrossRefPubMedPubMedCentral Chen IR, Wang SM, Liang CC, et al. Association of walking with survival and RRT among patients with CKD stages 3–5. Clin J Am Soc Nephrol. 2014;9(7):1183–9.CrossRefPubMedPubMedCentral
29.
go back to reference Saint-Maurice PF, Troiano RP, Bassett DR Jr, et al. Association of daily step count and step intensity with mortality among US adults. JAMA. 2020;323(12):1151–60.CrossRefPubMedPubMedCentral Saint-Maurice PF, Troiano RP, Bassett DR Jr, et al. Association of daily step count and step intensity with mortality among US adults. JAMA. 2020;323(12):1151–60.CrossRefPubMedPubMedCentral
30.
go back to reference Rico-Uribe LA, Caballero FF, Martín-María N, Cabello M, Ayuso-Mateos JL, Miret M. Association of loneliness with all-cause mortality: a meta-analysis. PLoS ONE. 2018;13(1):e0190033.CrossRefPubMedPubMedCentral Rico-Uribe LA, Caballero FF, Martín-María N, Cabello M, Ayuso-Mateos JL, Miret M. Association of loneliness with all-cause mortality: a meta-analysis. PLoS ONE. 2018;13(1):e0190033.CrossRefPubMedPubMedCentral
31.
go back to reference Steptoe A, Shankar A, Demakakos P, Wardle J. Social isolation, loneliness, and all-cause mortality in older men and women. Proc Natl Acad Sci USA. 2013;110(15):5797–801.CrossRefPubMedPubMedCentral Steptoe A, Shankar A, Demakakos P, Wardle J. Social isolation, loneliness, and all-cause mortality in older men and women. Proc Natl Acad Sci USA. 2013;110(15):5797–801.CrossRefPubMedPubMedCentral
32.
go back to reference Fletcher BR, Damery S, Aiyegbusi OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954.CrossRefPubMedPubMedCentral Fletcher BR, Damery S, Aiyegbusi OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954.CrossRefPubMedPubMedCentral
33.
34.
go back to reference Phyo A, Freak-Poli R, Craig H, et al. Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1596.CrossRefPubMedPubMedCentral Phyo A, Freak-Poli R, Craig H, et al. Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1596.CrossRefPubMedPubMedCentral
35.
go back to reference Jesky MD, Dutton M, Dasgupta I, et al. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLoS ONE. 2016;11(11):e0165675.CrossRefPubMedPubMedCentral Jesky MD, Dutton M, Dasgupta I, et al. Health-related quality of life impacts mortality but not progression to end-stage renal disease in pre-dialysis chronic kidney disease: a prospective observational study. PLoS ONE. 2016;11(11):e0165675.CrossRefPubMedPubMedCentral
36.
go back to reference Walker RL, Greenwood-Hickman MA, Bellettiere J, et al. Associations between physical function and device-based measures of physical activity and sedentary behavior patterns in older adults: moving beyond moderate-to-vigorous intensity physical activity. BMC Geriatr. 2021;21(1):216.CrossRefPubMedPubMedCentral Walker RL, Greenwood-Hickman MA, Bellettiere J, et al. Associations between physical function and device-based measures of physical activity and sedentary behavior patterns in older adults: moving beyond moderate-to-vigorous intensity physical activity. BMC Geriatr. 2021;21(1):216.CrossRefPubMedPubMedCentral
37.
go back to reference Gregg LP, Jain N, Carmody T, et al. Fatigue in nondialysis chronic kidney disease: correlates and association with kidney outcomes. Am J Nephrol. 2019;50(1):37–47.CrossRefPubMed Gregg LP, Jain N, Carmody T, et al. Fatigue in nondialysis chronic kidney disease: correlates and association with kidney outcomes. Am J Nephrol. 2019;50(1):37–47.CrossRefPubMed
38.
go back to reference Agarwal V, Smuck M, Tomkins-Lane C, Shah NH. Inferring physical function from wearable activity monitors: analysis of free-living activity data from patients with knee osteoarthritis. JMIR Mhealth Uhealth. 2018;6(12):e11315.CrossRefPubMedPubMedCentral Agarwal V, Smuck M, Tomkins-Lane C, Shah NH. Inferring physical function from wearable activity monitors: analysis of free-living activity data from patients with knee osteoarthritis. JMIR Mhealth Uhealth. 2018;6(12):e11315.CrossRefPubMedPubMedCentral
40.
41.
Metadata
Title
Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study
Authors
Ewelina Palmer
Ichha Johar
Dustin J. Little
Niklas Karlsson
Publication date
09-05-2024
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 7/2024
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-024-02853-6

Other articles of this Issue 7/2024

Advances in Therapy 7/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare